CERS
Cerus Corp
Price:  
2.12 
USD
Volume:  
1,605,428.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Cerus EV/EBITDA

-189.8%
Upside

As of 2024-03-05, the EV/EBITDA ratio of Cerus Corp (CERS) is -12.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Cerus's latest enterprise value is 445.34 mil USD. Cerus's TTM EBITDA according to its financial statements is -34.59 mil USD. Dividing these 2 quantities gives us the above Cerus EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.9x - 11.1x 7.2x
Forward P/E multiples 7.7x - 9.9x 9.2x
Fair Price (1.81) - (2.22) (1.90)
Upside -185.3% - -204.7% -189.8%
2.12 USD
Stock Price
(1.90) USD
Fair Price

Cerus EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-04 -12.87
2024-03-01 -13.19
2024-02-29 -13.19
2024-02-28 -13.29
2024-02-27 -13.71
2024-02-26 -13.35
2024-02-23 -13.35
2024-02-22 -13.40
2024-02-21 -13.50
2024-02-20 -13.87
2024-02-16 -14.13
2024-02-15 -14.29
2024-02-14 -13.95
2024-02-13 -13.14
2024-02-12 -14.18
2024-02-09 -14.13
2024-02-08 -13.82
2024-02-07 -13.29
2024-02-06 -13.45
2024-02-05 -11.62
2024-02-02 -11.98
2024-02-01 -12.09
2024-01-31 -11.25
2024-01-30 -11.77
2024-01-29 -12.61
2024-01-26 -11.57
2024-01-25 -11.41
2024-01-24 -11.20
2024-01-23 -11.41
2024-01-22 -11.20
2024-01-19 -10.99
2024-01-18 -10.62
2024-01-17 -10.47
2024-01-16 -10.52
2024-01-12 -10.65
2024-01-11 -11.28
2024-01-10 -12.35
2024-01-09 -12.46
2024-01-08 -12.61
2024-01-05 -12.04
2024-01-04 -12.40
2024-01-03 -12.40
2024-01-02 -13.08
2023-12-29 -13.08
2023-12-28 -13.61
2023-12-27 -13.82
2023-12-26 -13.56
2023-12-22 -13.56
2023-12-21 -13.45
2023-12-20 -12.82